Genelux Corporation Common Stock (GNLX) is a publicly traded Healthcare sector company. As of May 21, 2026, GNLX trades at $2.93 with a market cap of $127.80M and a P/E ratio of -3.41. GNLX moved +4.46% today. Year to date, GNLX is -15.80%; over the trailing twelve months it is +6.55%. Its 52-week range spans $1.99 to $8.54. Analyst consensus is strong buy with an average price target of $19.75. Rallies surfaces GNLX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Genelux Corporation Common Stock (GNLX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. GNLX moved +4.46% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $2.93 |
| Market Cap | $127.80M |
| P/E Ratio | -3.41 |
| EPS | $-0.85 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.54 |
| 52-Week Low | $1.99 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $8.00K |
| Net Income | $-33.58M |
| Gross Margin | 0.00% |
4 analysts cover GNLX: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.75.